|
|
Article: Eden Biodesign, operator of the UK National Biomanufacturing Centre (NBC) (Liverpool), and IntelliHep, the heparin-based drug development company located in the MerseyBIO Incubator (Liverpool) are to develop a large-scale manufacturing process.(Projects & Technology)(Brief article)
- Article from:
- Chemistry and Industry
- Article date:
- February 12, 2007
- Author:
CopyrightCOPYRIGHT 2007 Society of Chemical Industry. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Eden Biodesign, operator of the UK National Biomanufacturing Centre (NBC) (Liverpool), and IntelliHep, the heparin-based drug development company located in the MerseyBIO Incubator (Liverpool) are to develop a large-scale manufacturing process for heparin-based treatments for ...
Related newspaper, magazine, and journal articles:
|
|
Article: move.(News)
Daily Post (Liverpool, England);
January 11, 2006 ;
605 words
... ... engineering and technology transfer at the National Biomanufacturing Centre in Speke. David's appointment completes ... Northwest Regional Development Agency to run the National Biomanufacturing Centre, a pounds 34.25m initiative that is set ...
|
|